THE ADENOID CYSTIC CARCINOMA RESEARCH
Data sourced from IRS 990 public filings
THE ADENOID CYSTIC CARCINOMA RESEARCH FOUNDATION SUPPORTING RESEARCH INTO THE TREATMENT AND CURE OF ADENOID CYSTIC CARCINOMA.
THE ADENOID CYSTIC CARCINOMA RESEARCH has received 40 grants from 21 known foundation funders. Revenue decreased from $1,893,545 in 2023 to $1,146,195 in 2024. Most recent reported revenue: $1,146,195.
Annual Revenue
$1,146,195
Known Funders
21
Grants Received
40
Financial History
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2024 | $1,146,195 | $1,458,198 | $2,251,893 |
| 2023 | $1,893,545 | $1,872,720 | $2,690,770 |
| 2022 | $1,386,655 | $1,618,196 | $2,659,707 |
| 2021 | $2,427,133 | $2,071,023 | $3,133,519 |
| 2020 | $1,208,448 | $1,420,993 | $2,608,038 |
| 2019 | $2,103,655 | $1,225,852 | $2,646,923 |
| 2018 | $2,043,147 | $1,294,454 | $1,935,482 |
| 2017 | $1,602,683 | $1,164,728 | $1,623,360 |
Top Funders
LAS VEGAS, NV
SAN DIEGO, CA
MINNEAPOLIS, MN
MINNEAPOLIS, MN
MINNEAPOLIS, MN
Washington, DC
WASHINGTON, DC
NEW YORK, NY
NEW YORK, NY
MIROMAR LAKES, FL
Showing top 10 of 21 funders.
Key Personnel
From 2024 IRS 990 filing
NICOLE SPARDY BURR
DIRECTOR OF RESEARCH
EMMA KINLOCH
DIRECTOR
BOZHO TODORICH
DIRECTOR
DAVID MORSE
DIRECTOR
ELIZABETH WEHLAGE
DIRECTOR
MARNIE A KAUFMAN
DIRECTOR & CFO
RALPH MOLLIS
TREASURER
THOMAS DILENGE
BOARD VICE CHAIR
JEFFREY A KAUFMAN
EXECUTIVE DIRECTOR/BOARD C
Frequently Asked Questions
Other Nonprofits in Massachusetts
Unlock Full Nonprofit Data
Sign up for free to access the complete funder list, financial history, program details, key personnel, and smart matching.